InvestorsHub Logo
Post# of 4970008
Next 10
Followers 23
Posts 602
Boards Moderated 0
Alias Born 01/19/2009

Re: None

Friday, 02/08/2019 2:29:22 PM

Friday, February 08, 2019 2:29:22 PM

Post# of 4970008
$QBIO has become the target of big pharma because of their innovative glaucoma treatment in a space that hasn't had much innovation in 20 years.

https://www.theglobeandmail.com/investing/markets/stocks/QBIO/pressreleases/462127/

This is a low float stock that is tightly held and it has multiple upcoming catalysts according to the CEO :


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.